Danaher (DHR) PT Raised to $290 at TD Cowen

TD Cowen analyst Dan Brennan raised the price target on Danaher (NYSE: DHR) to $290.00 (from $280.00) while maintaining a Buy rating.

The analyst commented, "DHR traded up 7% post-Q1 results and we see more to go. Though the '24 guide was largely maintained, we see a clear upside bias as the Bioproduction (BP) inflection is beginning, plus Dx and Life Sci also showed strength. Our Buy thesis, based in part upon sales acceleration in high margin BP segment enabling EPS upside, was strengthened with 1Q results."

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Va Tech Wabag Ltd. (VATW:IN) PT Raised to INR2,410 at ICICI Securities
• Travel Food Services (TRAVELFO:IN) PT Raised to INR1,600 at ICICI Securities